Stay updated on HZN-825 in Systemic Sclerosis: Clinical Trial
Sign up to get notified when there's something new on the HZN-825 in Systemic Sclerosis: Clinical Trial page.

Latest updates to the HZN-825 in Systemic Sclerosis: Clinical Trial page
- Check6 days agoChange DetectedThe clinical trial page now displays the study record for HZN-825 in diffuse cutaneous systemic sclerosis, including that the trial was terminated for meeting pre-defined futility criteria. The record also provides study results, design, eligibility information, and supporting documents.SummaryDifference59%

- Check13 days agoChange DetectedThe site’s revision label changed from v3.7.2 to v3.8.0, while the study record remains inaccessible behind a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedThe study record page is showing a 403 Forbidden message, alongside a site-wide NIH notice about terminology updates.SummaryDifference2%

- Check27 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check34 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal HTML structure and a Home link, indicating restricted access to the study record rather than the original study content.SummaryDifference20%

Stay in the know with updates to HZN-825 in Systemic Sclerosis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HZN-825 in Systemic Sclerosis: Clinical Trial page.